04:44 PM EDT, 09/18/2025 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on September 16, 2025, sold 13,411 shares in Revolution Medicines ( RVMD ) for $614,558. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 958,761 common shares of the company, with 452,309 shares held directly and 506,452 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071725000349/xslF345X05/form4.xml